Here, our results indicated that the GPL-related gene LPCAT1 had effects on the endometrial cancer TME and clinical outcomes of EC patients, which might provide a novel prognostic biomarker and immunotherapy target for EC. The gene discussed is LPCAT1; the disease is endometrial cancer.